James M. Luther

4.7k citations

71 papers · 2.7k indexed · 1 hit paper · h-index 31

Endocrinology, Diabetes and Metabolism top 1%
Molecular Biology top 10%
Surgery top 5%
Cardiology and Cardiovascular Medicine top 5%
Pharmacology top 5%

Co-authors: Nancy J. Brown Kevin L. Schey Chang Yu Kristie L. Rose Agnes B. Fogo David L. Hachey Hui Nian Salisha Hill
Topics: Hormonal Regulation and Hypertension (32 papers)Eicosanoids and Hypertension Pharmacology (11 papers)Cardiovascular, Neuropeptides, and Oxidative Stress Research (9 papers)
Cited by: Endocrinology, Diabetes and Metabolism Biochemistry Cardiology and Cardiovascular Medicine
Journals: New England Journal of MedicineSHILAP Revista de lepidopterologíaThe Journal of Clinical Endocrinology & Metabolism
Partner nations: United States Australia United Kingdom

In The Last Decade

James M. Luther

69 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

2025 23 citations James M. Luther et al. profile →

Peers

Countries citing papers authored by James M. Luther

Since Specialization

Citations

This map shows the geographic impact of James M. Luther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Luther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Luther more than expected).

Fields of papers citing papers by James M. Luther

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Luther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Luther. The network helps show where James M. Luther may publish in the future.

Co-authorship network of co-authors of James M. Luther

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Luther. A scholar is included among the top collaborators of James M. Luther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Luther. James M. Luther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Somatic Mutations in MCOLN3 Are Associated With Aldosterone-Producing Adenomas 2025 ·Hypertension ·(unknown),Sascha Bandulik,(unknown),(unknown),Chandan Kumar‐Sinha,Aaron M. Udager,Antônio Marcondes Lerário,(unknown),Heather Wachtel,Debbie L. Cohen,James M. Luther,Thomas J. Giordano,Ute I. Scholl,(unknown),Bernt Popp,Adina F. Turcu,Richard Warth,William E. Rainey,Juilee Rege	2
2	Salt Sensitivity of Blood Pressure and Aldosterone: Interaction Between the Lysine-specific Demethylase 1 Gene, Sex, and Age 2022 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown),Mahyar Heydarpour,(unknown),James M. Luther,Paul N. Hopkins,Luminita H. Pojoga,Jonathan S. Williams	10
3	Recalibrating Interpretations of Aldosterone Assays Across the Physiologic Range: Immunoassay and Liquid Chromatography–Tandem Mass Spectrometry Measurements Under Multiple Controlled Conditions 2022 ·Journal of the Endocrine Society ·Jenifer M. Brown,Richard J. Auchus,(unknown),James M. Luther,Nicholas Yozamp,Anand Vaidya	24
4	The soluble epoxide hydrolase inhibitor GSK2256294 decreases the proportion of adipose pro-inflammatory T cells 2021 ·Prostaglandins & Other Lipid Mediators ·Mona Mashayekhi,Celestine N. Wanjalla,(unknown),(unknown),Kakali Ghoshal,Mark A. Pilkinton,Samuel Bailin,Curtis L. Gabriel,Ambra Pozzi,John R. Koethe,Nancy J. Brown,Spyros A. Kalams,James M. Luther	5
5	Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19 2020 ·Clinical Journal of the American Society of Nephrology ·Matthew A. Sparks,Andrew M. South,Paul A. Welling,James M. Luther,Jordana B. Cohen,James Brian Byrd,Louise M. Burrell,Daniel Batlle,Laurie A. Tomlinson,Vivek Bhalla,Michelle N. Rheault,María José Soler,(unknown),Swapnil Hiremath	57
6	Retrospective cohort study to characterise the blood pressure response to spironolactone in patients with apparent therapy-resistant hypertension using electronic medical record data 2020 ·BMJ Open ·(unknown),(unknown),Hui Nian,Chang Yu,James M. Luther,Nancy J. Brown	5
7	Under pressure—how to assess blood pressure in rodents: tail-cuff? 2019 ·Kidney International ·James M. Luther,Agnes B. Fogo	5
8	For what factors should we normalize urinary extracellular mRNA biomarkers? 2019 ·SHILAP Revista de lepidopterología ·(unknown),James M. Luther,James Brian Byrd	18
9	The Cytochrome P450 Slow Metabolizers CYP2C92 and CYP2C93 Directly Regulate Tumorigenesis via Reduced Epoxyeicosatrienoic Acid Production 2018 ·Cancer Research ·(unknown),Mahesha Gangadhariah,(unknown),Shaojun Mei,Shouzuo Wei,Roy Zent,James M. Luther,(unknown),Jorge H. Capdevila,John R. Falck,F. Peter Guengerich,Scott M. Williams,Ambra Pozzi	27
10	Early Urine Electrolyte Patterns in Patients with Acute Heart Failure 2018 ·ESC Heart Failure ·Sean P. Collins,Cathy A. Jenkins,Adrienne Baughman,Karen F. Miller,Alan B. Storrow,Jin H. Han,Nancy J. Brown,Dandan Liu,James M. Luther,Candace D. McNaughton,Wesley H. Self,Dungeng Peng,Jeffrey M. Testani,JoAnn Lindenfeld	31
11	Aldosterone in vascular and metabolic dysfunction 2015 ·Current Opinion in Nephrology & Hypertension ·James M. Luther	20
12	Activation of the Endogenous Renin-Angiotensin-Aldosterone System or Aldosterone Administration Increases Urinary Exosomal Sodium Channel Excretion 2015 ·Journal of the American Society of Nephrology ·Ying Qi,Xiaojing Wang,Kristie L. Rose,(unknown),Bing Zhang,Kevin L. Schey,James M. Luther	48
13	Effects of aldosterone on insulin sensitivity and secretion 2014 ·Steroids ·James M. Luther	83
14	Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension 2013 ·Journal of Hypertension ·(unknown),Hui Nian,Yu Chang,James M. Luther,Nancy J. Brown	30
15	Aldosterone deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in mice 2013 ·Diabetologia ·Pengfei Luo,(unknown),(unknown),Lin Zhu,(unknown),(unknown),Ambra Pozzi,John M. Stafford,James M. Luther	35
16	Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin-Angiotensin System in Humans 2011 ·American Journal of Hypertension ·Bindu Chamarthi,G. H. Williams,Vincent Ricchiuti,(unknown),P N Hopkins,James M. Luther,Xavier Jeunemaı̂tre,Abraham Thomas	118
17	Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT) 2011 ·PROTEOMICS ·Zhen Wang,Salisha Hill,James M. Luther,David L. Hachey,Kevin L. Schey	146
18	Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets 2011 ·Diabetologia ·James M. Luther,Pengfei Luo,(unknown),(unknown),Chunhua Dai,Tanya T. Whitfield,(unknown),David H. Wasserman,Alvin C. Powers,Nancy J. Brown	85
19	Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt 2009 ·Kidney International ·William Lea,(unknown),James M. Luther,Susan Fowler,(unknown),(unknown),Agnes B. Fogo,Nancy J. Brown	93
20	Angiotensin II Induces Interleukin-6 in Humans Through a Mineralocorticoid Receptor–Dependent Mechanism 2006 ·Hypertension ·James M. Luther,James V. Gainer,Laine J. Murphey,Chang Yu,Douglas E. Vaughan,Jason D. Morrow,Nancy J. Brown	125

About James M. Luther

James M. Luther is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Cardiology and Cardiovascular Medicine, having authored 71 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (32 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Biochemistry (218 citations) and Cardiology and Cardiovascular Medicine (556 citations). James M. Luther has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Nancy J. Brown, Kevin L. Schey, Chang Yu, Kristie L. Rose, Agnes B. Fogo, David L. Hachey, Hui Nian, Salisha Hill, Zhen Wang and Douglas E. Vaughan. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact